These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24953561)

  • 1. Wortmannin potentiates the combined effect of etoposide and cisplatin in human glioma cells.
    Pastwa E; Poplawski T; Lewandowska U; Somiari SB; Blasiak J; Somiari RI
    Int J Biochem Cell Biol; 2014 Aug; 53():423-31. PubMed ID: 24953561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells.
    de Campos-Nebel M; Larripa I; González-Cid M
    Mutat Res; 2008 Nov; 646(1-2):8-16. PubMed ID: 18812179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of ERK activation enhances the repair of double-stranded breaks via non-homologous end joining by increasing DNA-PKcs activation.
    Wei F; Yan J; Tang D; Lin X; He L; Xie Y; Tao L; Wang S
    Biochim Biophys Acta; 2013 Jan; 1833(1):90-100. PubMed ID: 23098854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus.
    DiBiase SJ; Zeng ZC; Chen R; Hyslop T; Curran WJ; Iliakis G
    Cancer Res; 2000 Mar; 60(5):1245-53. PubMed ID: 10728683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effect of three different topoisomerase II inhibitors combined with cisplatin in human glioblastoma cells sensitized with double strand break repair inhibitors.
    Macieja A; Kopa P; Galita G; Pastwa E; Majsterek I; Poplawski T
    Mol Biol Rep; 2019 Aug; 46(4):3625-3636. PubMed ID: 31020489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of chromosomal damage induced by etoposide in G2 phase in a DNA-PKcs-deficient context.
    Palmitelli M; de Campos-Nebel M; González-Cid M
    Chromosome Res; 2015 Dec; 23(4):719-32. PubMed ID: 26152239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA double-strand breaks repair inhibitors potentiates the combined effect of VP-16 and CDDP in human colorectal adenocarcinoma (LoVo) cells.
    Kopa P; Macieja A; Pastwa E; Majsterek I; Poplawski T
    Mol Biol Rep; 2021 Jan; 48(1):709-720. PubMed ID: 33389482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of DNA-dependent protein kinase sensitize cells to radiation without affecting DSB repair.
    Gustafsson AS; Abramenkovs A; Stenerlöw B
    Mutat Res; 2014 Nov; 769():1-10. PubMed ID: 25771720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting DNA-PKcs in a non-homologous end-joining pathway in response to DNA double-strand breaks.
    Dong J; Zhang T; Ren Y; Wang Z; Ling CC; He F; Li GC; Wang C; Wen B
    Oncotarget; 2017 Apr; 8(14):22662-22673. PubMed ID: 28186989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of DNA-PK potentiates the synergistic effect of NK314 and etoposide combination on human glioblastoma cells.
    Kopa P; Macieja A; Gulbas I; Pastwa E; Poplawski T
    Mol Biol Rep; 2020 Jan; 47(1):67-76. PubMed ID: 31583565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akt promotes post-irradiation survival of human tumor cells through initiation, progression, and termination of DNA-PKcs-dependent DNA double-strand break repair.
    Toulany M; Lee KJ; Fattah KR; Lin YF; Fehrenbacher B; Schaller M; Chen BP; Chen DJ; Rodemann HP
    Mol Cancer Res; 2012 Jul; 10(7):945-57. PubMed ID: 22596249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCR/ABL downregulates DNA-PK(CS)-dependent and upregulates backup non-homologous end joining in leukemic cells.
    Poplawski T; Blasiak J
    Mol Biol Rep; 2010 Jun; 37(5):2309-15. PubMed ID: 19697154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-PKcs deficiency inhibits glioblastoma cell-derived angiogenesis after ionizing radiation.
    Liu Y; Zhang L; Liu Y; Sun C; Zhang H; Miao G; Di CX; Zhou X; Zhou R; Wang Z
    J Cell Physiol; 2015 May; 230(5):1094-103. PubMed ID: 25294801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel histone deacetylase inhibitor TMU-35435 enhances etoposide cytotoxicity through the proteasomal degradation of DNA-PKcs in triple-negative breast cancer.
    Wu YH; Hong CW; Wang YC; Huang WJ; Yeh YL; Wang BJ; Wang YJ; Chiu HW
    Cancer Lett; 2017 Aug; 400():79-88. PubMed ID: 28450160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcs.
    Djuzenova CS; Fischer T; Katzer A; Sisario D; Korsa T; Steussloff G; Sukhorukov VL; Flentje M
    BMC Cancer; 2021 Nov; 21(1):1201. PubMed ID: 34763650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro.
    Toulany M; Dittmann K; Fehrenbacher B; Schaller M; Baumann M; Rodemann HP
    DNA Repair (Amst); 2008 Oct; 7(10):1746-56. PubMed ID: 18678286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactive competition between homologous recombination and non-homologous end joining.
    Allen C; Halbrook J; Nickoloff JA
    Mol Cancer Res; 2003 Oct; 1(12):913-20. PubMed ID: 14573792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-PKcs-dependent NHEJ pathway supports the progression of topoisomerase II poison-induced chromosome aberrant cells.
    Elguero ME; de Campos-Nebel M; González-Cid M
    Environ Mol Mutagen; 2012 Oct; 53(8):608-18. PubMed ID: 22987276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for PKCzeta in potentiation of the topoisomerase II activity and etoposide cytotoxicity by wortmannin.
    Reis C; Giocanti N; Hennequin C; Mégnin-Chanet F; Fernet M; Filomenko R; Bettaieb A; Solary E; Favaudon V
    Mol Cancer Ther; 2005 Oct; 4(10):1457-64. PubMed ID: 16227394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin.
    Ciszewski WM; Tavecchio M; Dastych J; Curtin NJ
    Breast Cancer Res Treat; 2014 Jan; 143(1):47-55. PubMed ID: 24292814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.